4.7 Article

Discovery of Plasmodium vivax N-Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of their Binding Mode

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 7, Pages 3578-3582

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm300040p

Keywords

-

Funding

  1. Medical Research Council (MRC) [G0900278, U117532067]
  2. Wellcome Trust [087792]
  3. Biotechnology and Biological Sciences Research Council [BB/D02014X/1]
  4. Biotechnology and Biological Sciences Research Council [BB/D02014X/1] Funding Source: researchfish
  5. Medical Research Council [MC_U117532067, MC_G1000806, G0900278] Funding Source: researchfish
  6. BBSRC [BB/D02014X/1] Funding Source: UKRI
  7. MRC [MC_U117532067, G0900278, MC_G1000806] Funding Source: UKRI

Ask authors/readers for more resources

N-Myristoyltransferase (NMT) is a prospective drug target against parasitic protozoa. Herein we report the successful discovery of a series of Plasmodium vivax NMT inhibitors by high-throughput screening. A high-resolution crystal structure of the hit compound in complex with NMT was obtained, allowing understanding of its novel binding mode. A set of analogues was designed and tested to define the chemical groups relevant for activity and selectivity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available